American International Group’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-836
Closed -$77K 3141
2022
Q1
$77K Sell
836
-59
-7% -$8.02K ﹤0.01% 2685
2021
Q4
$199K Sell
895
-9
-1% -$2.51K ﹤0.01% 2372
2021
Q3
$313K Buy
904
+16
+2% +$5.42K ﹤0.01% 2147
2021
Q2
$333 Sell
888
-15
-2% -$4.5K ﹤0.01% 2186
2021
Q1
$280 Buy
903
+2
+0.2% +$700 ﹤0.01% 2181
2020
Q4
$225 Sell
901
-26
-3% -$6.37K ﹤0.01% 2218
2020
Q3
$171K Sell
927
-4
-0.4% -$796 ﹤0.01% 2224
2020
Q2
$233K Buy
931
+222
+31% +$48.6K ﹤0.01% 2042
2020
Q1
$128K Sell
709
-41
-5% -$10.7K ﹤0.01% 2166
2019
Q4
$312K Buy
750
+557
+289% +$175K ﹤0.01% 1952
2019
Q3
$49K Sell
193
-1
-0.5% -$325 ﹤0.01% 2892
2019
Q2
$77K Buy
+194
New +$78.1K ﹤0.01% 2805

Other funds holding DTIL

American International Group's DTIL Position: Q2 2022 in Review

American International Group sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 836 shares — an estimated $77K sold.

American International Group first reported a position in DTIL in Q2 2019 and held it in 12 quarters. The position peaked at $313K in Q3 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • American International Group reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 836 Precision BioSciences shares in Q2 2022, an estimated $77K.
  • American International Group first reported a position in Precision BioSciences in Q2 2019 and held it in 12 quarters.
  • American International Group's Precision BioSciences position peaked at $313K in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.